Next generation probiotics is a broad term that refers to a new generation of probiotic products that are designed to provide enhanced benefits for human health. Probiotics are live microorganisms that, when consumed in adequate amounts, offer health benefits to the host. The NGPs enhance gastrointestinal immunity, maintain intestinal barrier integrity, produce beneficial metabolites, act against pathogens, and improve immunotherapy efficacy.
Highlights from Next Generation Probiotics Market Study
|Unit||Value (USD Million)|
The key Players profiled in the report are Pendulum Therapeutics Inc. (United States), Winclove Probiotics B.V. (Netherlands), Metabogen AB (Sweden), Exeliom Biosciences (France), TargEDys (France), Chr. Hansen A/S (Denmark), YSOPIA Bioscience (France), BioGaia (Sweden), A-Mansia Biotech (Belgium) and Evolve Biosystems (United States).
Geographic Breakdown and Segment Analysis
The Global Next Generation Probiotics market presents a comprehensive analysis of the Next Generation Probiotics market by end-user/application (Autoimmune Diseases, Glucose Management, Inflammatory Bowel Disease and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Next Generation Probiotics industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Next Generation Probiotics market
Analyst at AMA have segmented the market study of Global Next Generation Probiotics market by Type, Application and Region.
Influencing Trend:Increasing Use of Probiotics as Potential Biotherapeutic Agents
Market Growth Drivers:Increasing Prevalence of Digestive Disorders and Rise in Awareness of the Importance of Gut Health among People
Challenges:Highly Competitive With Numerous Players
Restraints:Stringent Rules and Regulations for Product Approval
Opportunities:Collaboration with Healthcare Professionals Such As Doctors, Nutritionists, and Dieticians, Presents an Opportunity for Market Growth
Market Developments Activities:In September 2022, TargEDys and Inoliva, have signed an agreement for the marketing and distribution of Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market
In July 2022, BioGaia launched a probiotic product to support children’s respiratory health, which aims to strengthen the immune system and support children’s upper respiratory health and In December 2020, Netherlands-based Winclove Probiotics is developing Novobiome, a new platform to bring human-derived, next-generation probiotics (NGPs) to the European market
Regulatory Insights:In the United States, the FDA regulates probiotics as dietary supplements. The FDA's Center for Food Safety and Applied Nutrition (CFSAN) oversees the safety and labeling of dietary supplements, including probiotic products. Manufacturers of probiotics are required to comply with FDA regulations, including good manufacturing practices (GMPs) and labeling requirements.
Major players have adopted various strategies such as expansions, investments, new product launches, and collaborations as their preferred strategies. Apart from this, the players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Key Target AudienceManufacturers, Suppliers, and Distributors, Potential Investors, Government Institutes, Regulatory Authorities, Research and Development Institutes, Market Research & Consulting Firms and Others